When should automatic auditory brainstem response test be used for newborn hearing screening?

dc.contributor.authorÜnlü, İlhan
dc.contributor.authorGüçlü, Ender
dc.contributor.authorYaman, Hüseyin
dc.date.accessioned2020-04-30T23:46:57Z
dc.date.available2020-04-30T23:46:57Z
dc.date.issued2015
dc.departmentDÜ, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümüen_US
dc.descriptionWOS: 000355031300003en_US
dc.descriptionPubMed: 25459495en_US
dc.description.abstractObjectives: The aim of this study was to investigate the referral rate and when automatic Auditory Brainstem Response (aABR) should be used for newborn hearing screening. Methods: The present study enrolled 2933 healthy full-term infants and 176 infants with perinatal risk factors. Hearing screening using Transient Evoked Otoacoustic Emissions (TEOAEs) was performed in newborns for the first time 5 days after birth except perinatal risk factors infants. The TEOAE was repeated to neonates failing to pass at the 15th day after birth. Neonates failing to pass the second TEOAE, repeated the test again at the 30th day after birth. Neonates failing to pass the third TEOAE were referred for the second stage screening using aABR. In addition, neonates with risk factors were tested with aABR directly. Results: In this research, 85 (2.9%) infants who could not pass the TEOAE and 176 infants exposed to perinatal risk factors, underwent the aABR test. In the aABR, 14(7.9%) of 176 infants exposed to perinatal risk factors and 10(11.7%) of 85 infants who could not pass the TEOAE failed to pass. As a result, hearing loss was detected in only 10 (0.34%) of 2933 healthy full-term infants. Conclusion: TEOAE should be performed at least twice in healthy full-term infants before aABR, because aABR is to be performed by specially trained personnel and takes a long time. In view of these results, it is our opinion that infants without perinatal risk factors should undergo TEOAE screening test and infants who did not pass control screening tests and have perinatal risk factors should absolutely undergo aABR test. But it should be remembered that TEOAE can cause a problem to miss auditory neuropathy in infants without perinatal risk factors. (C) 2014 Elsevier Ireland Ltd. All rights reserved.en_US
dc.identifier.doi10.1016/j.anl.2014.10.005en_US
dc.identifier.endpage202en_US
dc.identifier.issn0385-8146
dc.identifier.issn1879-1476
dc.identifier.issue3en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage199en_US
dc.identifier.urihttps://doi.org/10.1016/j.anl.2014.10.005
dc.identifier.urihttps://hdl.handle.net/20.500.12684/5398
dc.identifier.volume42en_US
dc.identifier.wosWOS:000355031300003en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakPubMeden_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherElsevier Sci Ltden_US
dc.relation.ispartofAuris Nasus Larynxen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectNewborn hearing screeningen_US
dc.subjectAuditory brainstem responseen_US
dc.subjectOtoacoustic emissionsen_US
dc.subjectHearing lossen_US
dc.titleWhen should automatic auditory brainstem response test be used for newborn hearing screening?en_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
5398.pdf
Boyut:
255.05 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text